Image
Stories
Mid-large buyout
Investments
We offer everything our portfolio companies need to grow: the insights of our committed experts, in-depth industry knowledge, prime access to global markets and a responsible approach to value creation. We have developed a diversified portfolio across various sectors of activity, including today’s top performers and the unicorns and leaders of tomorrow. It is built for success in both the short and long term.
Non-exhaustive portfolio.
Stories
Blocs de la page
232 result(s)
232 result(s)
Healthcare - Nov Santé
Commercetools
Cloud-based e-commerce software focused on APIs and micro services for real omnichannel customer experiences.
Growth
StatusIn portfolio
Investment date06/2023
SectorTech-enabled
LocationEurope
2BSI
2BSI is a materials and energy recovery specialist operating in niche markets
Infrastructure
StatusIn portfolio
Investment date07/2023
SectorTech-enabled
LocationEurope
Oncodesign
Created in 1995 by Philippe Genne, Oncodesign is a biopharmaceutical company specialized in preclinical pharmacological evaluation of new cancer therapies on behalf of pharmaceutical and biotechnology companies
Healthcare - Nov Santé
StatusIn portfolio
Investment date12/2023
SectorHealthcare
LocationEurope
Kinvent
Leader in connected solutions for physiotherapists and sport practitioners
Healthcare - Nov Santé
StatusIn portfolio
Investment date12/2023
SectorHealthcare
LocationEurope
Information - Individual investors
Eurazeo Investment Manager (EIM) and Eurazeo Mid Cap (EMC) are merging to form Eurazeo Global Investor (EGI)